15 completed. 15 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 15 |
| Phase 1 | 2 | Completed 2 |
Follow Immunoenzyme Techniques: new trials by email Literature Review of Immunoenzyme Techniques trials Research Report on Immunoenzyme Techniques
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma ipilimumab, cyclophosphamide, biopsy - Recurrent Melanoma, Stage IV Melanoma | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 10 | 2009-02-01 | 2017-04-19 |
| Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer allogeneic GM-CSF-secreting breast cancer vaccine, trastuzumab, cyclophosphamide - Breast Cancer | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 | 2008-12-01 | 2018-09-26 |
| Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer imiquimod, Abraxane, laboratory biomarker analysis - Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Completed | University of Washington | 15 | 2008-12-01 | 2018-01-02 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, protein expression analysis - Lung Cancer | Phase 2 | Completed | Greg Otterson | 63 | 2008-08-14 | 2018-04-02 |
| Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck docetaxel, erlotinib hydrochloride, fluorescence in situ hybridization - Head and Neck Cancer | Phase 2 | Completed | Case Comprehensive Cancer Center | 43 | 2007-11-19 | 2024-08-22 |
| Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection S-adenosyl-L-methionine disulfate p-toluene-sulfonate, placebo, laboratory biomarker analysis - Adult Primary Liver Cancer, Hepatitis C Infection | Phase 2 | Completed | Chao Family Comprehensive Cancer Center | 110 | 2007-10-01 | 2018-08-10 |
| Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma temozolomide, protein expression analysis, reverse transcriptase-polymerase chain reaction - Brain and Central Nervous System Tumors | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 47 | 2007-06-01 | 2016-02-29 |
| Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery bevacizumab, dexamethasone, floxuridine - Liver Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 22 | 2007-05-09 | 2024-12-10 |
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment erlotinib hydrochloride, gene expression analysis, protein expression analysis - Lung Cancer | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 40 | 2006-09-01 | 2010-08-09 |
| Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer docetaxel, bortezomib, laboratory biomarker analysis - Non-small Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 81 | 2006-07-01 | 2017-12-05 |
| Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) therapeutic autologous dendritic cells, aromatase inhibition therapy, cyclophosphamide - Breast Cancer | Phase 2 | Completed | University of Nebraska | 17 | 2006-05-01 | 2023-09-29 |
| Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer sargramostim, flow cytometry, immunoenzyme technique - Kidney Cancer, Lung Cancer | Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 8 | 2006-01-01 | 2020-03-05 |
| Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer Docetaxel, Thalidomide, Prednisone - Prostatic Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 73 | 2005-04-19 | 2018-04-20 |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors bortezomib, pemetrexed disodium, gene expression analysis - Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Completed | University of California, Davis | 27 | 2005-03-01 | 2018-10-31 |
| ABT-510 in Treating Patients With Metastatic Melanoma ABT-510, immunoenzyme technique, immunohistochemistry staining method - Melanoma (Skin) | Phase 2 | Completed | Mayo Clinic | 42 | 2004-11-01 | 2011-05-16 |
Carcinoma, Non-Small-Cell Lung (5) · Lung Neoplasms (4) · Breast Neoplasms (3) · Breast Neoplasms, Male (2) · Carcinoma, Hepatocellular (2) · Melanoma (2) · Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Glioblastoma (1) · Glioma (1) · Glioma, Subependymal (1) · Gliosarcoma (1)
Memorial Sloan Kettering Cancer Center (2) · National Cancer Institute (NCI) (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Barbara Ann Karmanos Cancer Institute (1) · Case Comprehensive Cancer Center (1) · Chao Family Comprehensive Cancer Center (1) · Fred Hutchinson Cancer Center (1) · Greg Otterson (1) · Mayo Clinic (1) · University of California, Davis (1) · University of Nebraska (1) · University of Washington (1)
United States (14)
Angela Davies, MD (1) · Antonio Omuro, MD (1) · Aude Chapuis (1) · Charles M. Rudin, MD, PhD (1) · Elizabeth C Reed, MD (1) · Gregory A. Otterson, MD (1) · John Hoefs (1) · Kenneth H Cowan, MD, PhD (1) · Leisha A. Emens, MD, PhD (1) · Lupe Salazar (1) · Min Yao, MD (1) · Peter J. Littrup, MD (1) · Primo Lara (1) · Ravi Madan, M.D. (1) · Svetomir Markovic, MD, PhD (1)
PMID 17551310, PMID 18090584, PMID 21677464, PMID 23243055, PMID 26123189, PMID 26130251, PMID 27269940, PMID 28114604, PMID 31319977, PMID 35135810
P30CA006973 (2), K12CA076930 (1), N01CM17101 (1), N01CN35160 (1), P30CA008748 (1), P30CA015083 (1), P30CA022453 (1), P30CA036727 (1), R01CA138521 (1)